Skip to main content

Advertisement

SpringerLink
Log in

Clinical Trials Report: Sumatriptan–Naproxen Combination for Symptomatic Treatment of Comorbid Dysmenorrhea and Migraine

  • Clinical Trial Report
  • Published:
Current Pain and Headache Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Headache Classification Subcommittee of the International Headache Society: The International Classification of Headache Disorders: 2nd edition. Cephalalgia 2004, 24(Suppl 1):1–60.

    Google Scholar 

  2. Stewart WF, Wood C, Reed ML, et al.: Cumulative lifetime migraine incidence in women and men. Cephalalgia 2008, 28:1170–1178.

    Article  CAS  PubMed  Google Scholar 

  3. MacGregor EA, Brandes J, Eikermann A, Giammarco R: Impact of migraine on patients and their families: the Migraine And Zolmitriptan Evaluation (MAZE) survey: Phase III. Curr Med Res Opin 2004, 20:1143–1150. (Published erratum appears in Curr Med Res Opin 2004, 20:1143–1150.)

    Google Scholar 

  4. MacGregor EA, Hackshaw A: Prevalence of migraine on each day of the natural menstrual cycle. Neurology 2004, 63:351–353.

    PubMed  Google Scholar 

  5. Marjoribanks J, Proctor M, Farquhar C, Derks RS: Nonsteroidal anti-inflammatory drugs for dysmenorrhoea. Cochrane Database Syst Rev 2010, (1):CD001751.

  6. Suthisisang CC, Poolsup N, Suksomboon N, et al.: Meta-analysis of the efficacy and safety of naproxen sodium in the acute treatment of migraine. Headache 2010, 50:808–818

    Article  PubMed  Google Scholar 

  7. McCrory DC, Gray RN: Oral sumatriptan for acute migraine. Cochrane Database Syst Rev 2003, (3):CD002915.

  8. Brandes JL, Kudrow D, Stark SR, et al.: Sumatriptan-naproxen for acute treatment of migraine: a randomized trial. JAMA 2007, 297:1443–1454.

    Article  CAS  PubMed  Google Scholar 

  9. Allais G, Bussone G, De Lorenzo C, et al.: Naproxen sodium in short-term prophylaxis of pure menstrual migraine: pathophysiological and clinical considerations. Neurol Sci 2007, 28(Suppl 2):S225–S228.

    Article  PubMed  Google Scholar 

  10. Pringsheim T, Davenport WJ, Dodick D: Acute treatment and prevention of menstrually related migraine headache: Evidence-based review. Neurology 2008, 70:1555–1563.

    Article  CAS  PubMed  Google Scholar 

Download references

Disclosure

Professor Anne MacGregor provides consultancy to Addex Pharmaceuticals, AstraZeneca, BTG International Ltd., Endo Pharmaceuticals, The Menarini Group, Merck & Co., and Pozen, and has received research funding from Addex Pharmaceuticals, Endo Pharmaceuticals and Merck & Co.

Author information

Authors and Affiliations

  1. The City of London Migraine Clinic, 22 Charterhouse Square, London, EC1M 6DX, UK

    E. Anne MacGregor

  2. Centre for Neuroscience and Trauma, Blizard Institute of Cell and Molecular Science, Barts and the London School of Medicine and Dentistry, London, UK

    E. Anne MacGregor

Authors
  1. E. Anne MacGregor
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to E. Anne MacGregor.

Rights and permissions

Reprints and permissions

About this article

Cite this article

MacGregor, E.A. Clinical Trials Report: Sumatriptan–Naproxen Combination for Symptomatic Treatment of Comorbid Dysmenorrhea and Migraine. Curr Pain Headache Rep 14, 328–330 (2010). https://doi.org/10.1007/s11916-010-0134-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11916-010-0134-6

Keywords

Search

Navigation